Erciyes University Nephrology Department
Kayseri, 38039, Turkey (Türkiye)
NCT Number: NCT01659333
Dry weight (DW) assessment is essential for the efficient treatment of peritoneal dialysis (PD) patients but so far objective methods for DW assessment have not been established for daily clinical practice. Our aim was to evaluate hydration state in PD patients by using a body composition monitor (BCM) and calf bioimpedance (c-BI) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels and to compare both methods with arterial stiffness.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Kayseri, 38039, Turkey (Türkiye)
We evaluated 60 patients using a new BCM device that implies a validated body composition model. This method allows correct quantification of extracellular fluid overload or deficiency (normal limits:-1.1 to +1.1L). Patients were assigned to normo and hypervolemic groups according to BCM results. Also, normalized calf resistivity (nRho) was calculated from resistance at 5 Khz using c-BI and the levels of NT-proBNP were measured in all study patients. The analyses of arterial stiffness were performed by using the pulse wave velocity (PWV) technique on the patients. All patients underwent conventional echocardiography and their left ventricular diastolic functions were evaluated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: One year
TC Erciyes University
Other
Volume Status in Peritoneal Dialysis Patients With Using Different Determining Methods.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01045980
Cardiomegaly, Cardiovascular Diseases
Hamilton, Ontario, Canada
View Trial DetailsNCT02338128
Disorders Associated With Peritoneal Dialysis, Hyperuricemia
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT01581996
Chronic Disease, Chronic Kidney Failure
Torrance, California, United States
View Trial DetailsNCT01021878
Disorders Associated With Peritoneal Dialysis
Divinópolis, Minas Gerais, Brazil
View Trial Details